Antibiotic therapy for chorioamnionitis to reduce the global burden of associated disease

Clark T. Johnson, Rebecca R. Adami, Azadeh Farzin

Research output: Contribution to journalShort surveypeer-review

7 Scopus citations


Chorioamnionitis is associated with significant maternal and neonatal morbidity and mortality throughout the world. In developed countries, great progress has been made to minimize the impact of chorioamnionitis, through timely diagnosis and appropriate treatment. In the global setting, where many women deliver outside the healthcare facilities, this diagnosis is frequently overlooked and not properly treated. In addition to its impact on maternal health, a significant proportion of neonatal morbidity and mortality can be prevented by both recognition and access to readily available treatment. With the increasing focus on saving the most vulnerable members of society, we echo the need for providing parturient women with suspected chorioamnionitis universal access to appropriate therapy. We describe known effective antibiotic therapies for chorioamnionitis and provide an overview of additional potential antimicrobial treatments that might be effectively implemented in areas with limited access to care.

Original languageEnglish (US)
Article number97
JournalFrontiers in Pharmacology
Issue numberMAR
StatePublished - Mar 14 2017


  • Chorioamnionitis
  • Global maternal health
  • Intraamniotic infection
  • Intrapartum antibiotics
  • Neonatal sepsis

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Antibiotic therapy for chorioamnionitis to reduce the global burden of associated disease'. Together they form a unique fingerprint.

Cite this